CONMED Corp 8-K

What Happened

• CONMED Corporation (CNMD) announced its financial results for the quarter ended March 31, 2026 in a press release dated April 29, 2026. The press release was furnished as Exhibit 99.1 to a Current Report on Form 8-K filed April 29, 2026.
• The Form 8-K was signed by Andrew Moller, Interim Principal Financial Officer and VP, Corporate Controller, on April 29, 2026.

Key Details

• Event: Q1 2026 financial results announced (quarter ended March 31, 2026).
• Filing date: April 29, 2026 (Form 8-K, Items 2.02 and 9.01).
• Exhibit: Press release attached as Exhibit 99.1; Inline XBRL cover page data included as Exhibit 104.
• Signatory: Andrew Moller, Interim Principal Financial Officer / VP, Corporate Controller.

Why It Matters

• The press release contains CONMED’s latest quarterly earnings and revenue figures, which are material for assessing near-term performance and valuation.
• Investors should read the attached press release for specific metrics (revenue, earnings per share, margins, and any guidance or management commentary) because these items can affect short-term stock movement and inform longer-term analysis.
• This report furnishes — rather than separately files — the press release on Form 8-K, so the attached exhibit is the primary source for the detailed financial and operational results.